SE426491B - Sett att framstella kristallint, optiskt rent dipilokarpiniumpamoat - Google Patents

Sett att framstella kristallint, optiskt rent dipilokarpiniumpamoat

Info

Publication number
SE426491B
SE426491B SE7610217A SE7610217A SE426491B SE 426491 B SE426491 B SE 426491B SE 7610217 A SE7610217 A SE 7610217A SE 7610217 A SE7610217 A SE 7610217A SE 426491 B SE426491 B SE 426491B
Authority
SE
Sweden
Prior art keywords
optically pure
make crystalline
dipilocarpinium
pamoate
dipilocarpinium pamoate
Prior art date
Application number
SE7610217A
Other languages
English (en)
Swedish (sv)
Other versions
SE7610217L (sv
Inventor
R L Smith
T-J Lee
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7610217L publication Critical patent/SE7610217L/
Publication of SE426491B publication Critical patent/SE426491B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7610217A 1975-10-01 1976-09-15 Sett att framstella kristallint, optiskt rent dipilokarpiniumpamoat SE426491B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/618,538 US4076942A (en) 1975-10-01 1975-10-01 Crystalline dipilocarpinium pamoate

Publications (2)

Publication Number Publication Date
SE7610217L SE7610217L (sv) 1977-04-02
SE426491B true SE426491B (sv) 1983-01-24

Family

ID=24478126

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7610217A SE426491B (sv) 1975-10-01 1976-09-15 Sett att framstella kristallint, optiskt rent dipilokarpiniumpamoat

Country Status (9)

Country Link
US (1) US4076942A (de)
JP (2) JPS5244220A (de)
CH (1) CH620689A5 (de)
DE (1) DE2644250C3 (de)
DK (1) DK415576A (de)
FR (1) FR2326190A1 (de)
GB (1) GB1531030A (de)
NL (1) NL7610207A (de)
SE (1) SE426491B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6239977U (de) * 1985-08-28 1987-03-10
WO1995001984A1 (en) * 1993-07-06 1995-01-19 Polis A.G. Process for the extraction and purification of alkaloids
KR100334167B1 (ko) * 1997-05-08 2002-11-22 삼성종합화학주식회사 알파-올레핀중합방법
US6617321B2 (en) 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
ATE511512T1 (de) * 2005-01-05 2011-06-15 Lilly Co Eli Olanzapinpamoat-dihydrat
WO2019097318A1 (en) 2017-11-17 2019-05-23 Cellix Bio Private Limited Compositions and methods for the treatment of eye disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK137946B (da) * 1973-12-17 1978-06-12 Merck & Co Inc Bæremedium i fast form til anvendelse i ophthalmiske præparater.

Also Published As

Publication number Publication date
JPS5244220A (en) 1977-04-07
JPS5649379A (en) 1981-05-02
DE2644250C3 (de) 1980-09-11
FR2326190A1 (fr) 1977-04-29
JPS607995B2 (ja) 1985-02-28
NL7610207A (nl) 1977-04-05
US4076942A (en) 1978-02-28
FR2326190B1 (de) 1980-11-07
DK415576A (da) 1977-04-02
JPS5748072B2 (de) 1982-10-14
GB1531030A (en) 1978-11-01
DE2644250B2 (de) 1980-01-10
CH620689A5 (de) 1980-12-15
DE2644250A1 (de) 1977-04-14
SE7610217L (sv) 1977-04-02

Similar Documents

Publication Publication Date Title
SE433222B (sv) Sett att framstella modifierad polysackarid
SE413237B (sv) Sett att framstella finkornig, amorf, felld kiseldioxid
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE7800657L (sv) Sett att framstella trimetylolalkaner
SE7604837L (sv) Sett att inforliva gas i karamell
SE433492B (sv) Sett att framstella fenylettiksyraderivat
SE7612532L (sv) Sett att framstella grundpalar
SE441042B (sv) Sett att pavisa rheumatoida faktorer
SE435928B (sv) Sett att framstella nya 3-aryl-oxazolidin-2-oner
SE432256B (sv) Sett att framstella cellulosaalkyletrar
SE425736B (sv) Sett att framstella kromanon-(4)
SE420407B (sv) Sett att framstella nya bicyklo (2,2,1) hept-5-en-foreningar
SE430687B (sv) Sett att framstella hexanitrostilben
SE419440B (sv) Sett att framstella somatostatinanaloger
SE7602729L (sv) Sett att framstella nya indolylalkylpiperidiner
SE420732B (sv) Sett att framstella 4-gonen-3-oner
SE426491B (sv) Sett att framstella kristallint, optiskt rent dipilokarpiniumpamoat
SE425321B (sv) Sett att reducera vanadinoxider
SE424991B (sv) Sett att framstella nya 5-fenyl-oxazolidinoner
SE410733B (sv) Sett att framstella vissa angivna oximetrar
SE398436C (sv) Sett for jordfri vextodling
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE434397B (sv) Sett att framstella bens-acyl-bensimidazol-2-derivat
SE7607171L (sv) Sett att framstella indolokinoliziner
SE433213B (sv) Sett att framstella 2 -fenyl-3-amino-benso/b/tiofenderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7610217-7

Effective date: 19880622

Format of ref document f/p: F